In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Veropharm

Division of Abbott Laboratories Inc.
www.veropharm.ru

Latest From Veropharm

JPM15: Abbott Eyes Emerging Markets Only For Branded Generics Biz

Just in case the sight of Abbott divesting its branded generics businesses in developed markets to Mylan was not a clear enough signal of the company’s intention to focus solely on emerging markets, Michael J. Warmuth , the EVP with responsibility for the business, took the opportunity to spell it out at the recent JP Morgan Healthcare conference.

BioPharmaceutical Business Strategies

Emerging Markets Earnings: Abbott Laboratories Casts Fortune Abroad

Emerging markets now account for nearly half of Abbott Laboratories sales – a figure set to grow through regional focus and acquisitions, leading Chicago-based CEO Miles White and other executives to skip over vast portions of the globe in the third quarter earnings call.

BioPharmaceutical Consumer

Emerging Markets Earnings: Abbott Laboratories Casts Fortune Abroad

Emerging markets now account for nearly half of Abbott Laboratories sales – a figure set to grow through regional focus and acquisitions, leading Chicago-based CEO Miles White and other executives to skip over vast portions of the globe in the third quarter earnings call.

BioPharmaceutical Consumer

Emerging Markets Earnings Roundup: Abbott Laboratories (Part 2)

Abbott Laboratories now sees 40% of sales from emerging markets and has said a corner has been turned on its dairy nutrition business in China.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Eastern Europe
        • Russia
  • Parent & Subsidiaries
  • Abbott Laboratories Inc.
  • Senior Management
  • Marina Penkova, CEO
    Maksutova Nadiya, CFO
    Eduard Lopatukhin, Sr. Exec., R&D
    Ilya Nilva, Mktg. Dir.
  • Contact Info
  • Veropharm
    Phone: 495 792-53-30
    10-2-1, Ochakovskoe shosse
    Moscow, 119530
    Russia
Advertisement
Advertisement
UsernamePublicRestriction

Register